Patent application number | Description | Published |
20080269627 | Method and Apparatus for Sensing Improvement Using Pressure Data - Method and apparatus for sensing improvement using pressure data. The method and apparatus may be used in an implantable medical device to confirm that an EGM event signifies a true mechanical cardiac activity and not just electrical oversensing. The mechanical activity may be used to create a mechanical marker channel in the implantable medical device. | 10-30-2008 |
20090204194 | MEDICAL SYSTEM INCLUDING A NOVEL BIPOLAR PACING PAIR - A medical system includes a first low voltage electrode adapted for intimate contact with tissue at an implant site, in order to provide pacing stimulation in conjunction with a second low voltage electrode. A porous layer is formed over the second electrode; the porous layer allows conduction therethrough while preventing contact between the second electrode and tissue in proximity to the implant site. | 08-13-2009 |
20090259269 | METHOD AND APPARATUS FOR DETECTING AND TREATING TACHYARRHYTHMIAS INCORPORATING DIAGNOSTIC/THERAPEUTIC PACING TECHNIQUES - An implantable medical device (IMD) and methods of operating the same to treat a tachyarrhythmia are disclosed herein. In accordance with this method, an arrhythmia of the heart is classified based on one or more supraventricular tachycardia (SVT) rejection rules, which differentiate between a first group of heart rhythms that do not require treatment and a second group of heart rhythms that possibly require treatment. Diagnostic/therapeutic pacing can then be performed to further discriminate the second group of heart rhythms as being within a first sub-group of heart rhythms and a second sub-group of heart rhythms which are to be treated by applying a ventricular tachycardia (VT)/ventricular fibrillation (VF) therapy sequence. In another implementation, the order in which the IMD performs diagnostic/therapeutic pacing and analyzes passive detection and classification criteria can be reversed. | 10-15-2009 |
20090292331 | METHOD AND APPARATUS FOR IDENTIFYING OVERSENSING USING FAR-FIELD INTRACARDIAC ELECTROGRAMS AND MARKER CHANNELS - A method for identifying and classifying various types of oversensing in implantable medical devices (IMDs), such as implantable cardioverter defibrillators (ICDs), to assist a physician in choosing corrective action to reduce the likelihood of oversensing and inappropriate therapy delivery. Far-field electrogram (EGM) signals are analyzed to detect the occurrence of R-waves, and the result is compared to the number and pattern of R-waves sensed by the IMD and indicated on the marker channel. A marker channel with more sensed R-waves than indicated by analysis of the far-field EGM indicates the presence of oversensing, including double-counting of R-waves, T-wave oversensing, lead malfunction or failure, poor lead connections, noise associated with electromagnetic interference, non-cardiac myopotentials, etc. Identification of the type of oversensing may be determined by analysis of the number and pattern of marker channel sensed R-waves with respect to the timing of the R-waves detected from the far-field EGM. | 11-26-2009 |
20100114206 | Patient Interface Device and Therapy Delivery System - A method and system for diagnosing a medical condition, alerting a patient that a therapy is impending, and allowing the patient to override or modify the impending therapy are provided. The system may include an implantable medical device (“IMD”) and a patient interface device. The IMD may sense a physiological parameter within a patient, determine whether the physiological parameter qualifies for therapy based on a therapy criteria, and alert the patient via the patient interface device that therapy is impending if the physiological parameter qualifies for therapy. The patient may be given an opportunity to respond to the alert with the patient interface device and send an therapy modification indication if the therapy is not needed or wanted. The IMD may wait a predetermined period of time for the patient response and deliver the therapy if the patient response is not transmitted before expiration of the predetermined period of time or withhold the therapy if the patient overrides the delivery of the therapy within the predetermined period of time. The IMD may adjust one or more operational settings applied during its operation in response to the activity of the system. The patient interface device may be configured to avoid accidental override or modification of the delivery of the therapy. | 05-06-2010 |
20100185109 | "BLURRED TEMPLATE" APPROACH FOR ARRHYTHMIA DETECTION - An implantable medical device and associated method sense cardiac signals for deriving a template representing a known EGM waveform morphology and for classifying an unknown waveform morphology. A boundary of the template, offset from the template, is computed and compared to an unknown waveform morphology for classifying the unknown waveform morphology. | 07-22-2010 |
20100191301 | HYBRID SINGLE-CHAMBER TO SIMULTANEOUS PACING METHOD FOR DISCRIMINATION OF TACHYCARDIAS - A cardiac medical device and associated method control delivery of anti-tachycardia pacing (ATP) in response to detecting tachycardia. In one embodiment, an initial set of single chamber pacing pulses are delivered in a single one of the atrium and the ventricle, the other one of the atrium and the ventricle being a non-paced chamber during the initial set of single chamber pacing pulses. The device detects simultaneity between a sensed event in the non-paced chamber and one of the single chamber pacing pulses and delivers ATP in both the atrium and the ventricle in response to detecting the simultaneity. | 07-29-2010 |
20100198290 | DISTANCE-BASED ANALYSIS OF RETURN CYCLES FOR TACHYCARDIA DISCRIMINATION - A medical device and associated method classify a tachycardia according to a site of origin of the tachycardia. Cardiac signals are sensed and a tachycardia event is detected in response to the sensed cardiac signals. Pacing pulses are delivered and a time interval corresponding to a distance traversed by a depolarization associated with the last one of the pacing pulses from a site of delivery of the plurality of pacing pulses is determined. The tachycardia event is classified according to a site of origin in response to the determined time interval. | 08-05-2010 |
20100241180 | COMBINED HEMODYNAMIC AND EGM-BASED ARRHYTHMIA DETECTION - A medical device and associated method for detecting arrhythmias that includes electrodes for sensing cardiac electrical signals and a hemodynamic sensor for sensing a hemodynamic signal. An episode of cardiac electrical event intervals meeting cardiac arrhythmia detection criteria is detected from the sensed electrical signals. Cardiac mechanical events and/or cardiac mechanical event intervals are measured from the hemodynamic signal and used to withhold or confirm a cardiac arrhythmia detection of the episode. | 09-23-2010 |
20100241182 | COMBINED HEMODYNAMIC AND EGM-BASED ARRHYTHMIA DETECTION - A medical device and associated method for detecting arrhythmias that includes sensing cardiac electrical signals and cardiac hemodynamic signals, determining a long-term baseline hemodynamic measurement in response to a plurality of the sensed cardiac hemodynaic signals, detecting a period of increased metabolic demand in response to the sensed cardiac electrical signals, determining a sinus tachycardia baseline hemodynamic measurement in response sensing of cardiac hemododynamic signals during the detected period of increased metabolic demand, and detecting the arrhythmia and delivering therapy in response to one of only the sensed cardiac electrical signals and the sensed cardiac electrical signals in combination with one or both of the determined long-term baseline hemodynamic measurement and the sinus tachycardia baseline hemodynamic measurement | 09-23-2010 |
20110077703 | PACE DISCRIMINATION OF TACHYCARDIA USING ATRIAL-VENTRICULAR PACING - A cardiac medical device and associated method control delivery of dual chamber burst pacing pulses in response to detecting tachycardia. In one embodiment, a single chamber pacing pulse is delivered in response to detecting a tachycardia. Dual chamber pacing pulses are delivered subsequent to the single chamber pacing pulse. An intrinsic depolarization is sensed subsequent to delivering the dual chamber pacing pulses. The tachycardia episode is classified in response to the sensed intrinsic depolarization. | 03-31-2011 |
20110077704 | PACE DISCRIMINATION OF TACHYCARDIA USING ATRIAL-VENTRICULAR PACING - A cardiac medical device and associated method control delivery of dual chamber burst pacing pulses in response to detecting tachycardia. A number of cardiac cycles occurring in a first cardiac chamber are identified subsequent to the dual chamber pacing pulses. The number of sensed intrinsic events occurring in a second cardiac chamber during the first chamber cardiac cycles is determined as a number of second chamber events. The tachycardia episode is classified in response to the number of second chamber events. | 03-31-2011 |
20110077705 | PACE DISCRIMINATION OF TACHYCARDIA USING ATRIAL-VENTRICULAR PACING - A cardiac medical device and associated method control delivery of dual chamber burst pacing pulses in response to detecting tachycardia. In one embodiment, a single chamber pacing pulse is delivered in response to detecting a tachycardia. Dual chamber pacing pulses are delivered subsequent to the single chamber pacing pulse. An intrinsic depolarization is sensed subsequent to delivering the dual chamber pacing pulses. The tachycardia episode is classified in response to the sensed intrinsic depolarization. | 03-31-2011 |
20110112417 | METHOD AND APPARATUS FOR POST-PROCESSING OF EPISODES DETECTED BY A MEDICAL DEVICE - A method and system for determining undersensing during post-processing of sensing data generated by a medical device that includes transmitting a plurality of stored sensing data generated by the medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, and determines whether one of a predetermined number of undersensing criteria have been met in response to the transmitted data. | 05-12-2011 |
20110201952 | METHOD AND APPARATUS FOR SENSING IMPROVEMENT USING PRESSURE DATA - A method and apparatus for sensing improvement using pressure data. The method and apparatus may be used in an implantable medical device to confirm that an EGM event signifies a true mechanical cardiac activity and not just electrical oversensing. The mechanical activity may be used to create a mechanical marker channel in the implantable medical device. | 08-18-2011 |
20110270109 | METHOD AND APPARATUS FOR DETECTING AND DISCRIMINATING TACHYCARDIA - A medical device and associated method obtaining cardiac event intervals corresponding to a tachycardia interval. Evidence of a rhythm breaking point is obtained in response to sensing a cardiac event having a morphology corresponding to a supraventricular beat. A non-treatable rhythm is detected in response to the plurality of cardiac event intervals and the evidence of the rhythm breaking point. | 11-03-2011 |
20120165810 | IMPLANTED DEVICE DATA TO GUIDE ABLATION THERAPY - A medical device system and associated method for guiding ablation therapy sense cardiac signals using implantable electrodes and detect spontaneous cardiac events from the sensed cardiac signals. Pacing pulses are delivered in response to detecting a spontaneous cardiac event and a return cycle length is measured. The spontaneous cardiac event is clustered with a previously detected cardiac event in response to the measured return cycle length. Data corresponding to the clustered cardiac events is displayed to guide an ablation therapy. | 06-28-2012 |
20120165811 | IMPLANTED DEVICE DATA TO GUIDE ABLATION THERAPY - A medical device system and associated method for guiding ablation therapy sense cardiac signals using implantable electrodes and detect spontaneous cardiac events from the sensed cardiac signals. Pacing pulses are delivered and a return cycle length is measured in response to the plurality of pacing pulses. The spontaneous cardiac event is clustered with a previously detected cardiac event in response to the measured return cycle length, and a targeted ablation site is estimated in response to the measured return cycle length. A transit time interval, corresponding to a distance traversed by a depolarization associated with a last one of the plurality of pacing pulses when a reset condition occurs, is computed using the return cycle length, and the ablation site is estimated in response to the computed transit time interval. | 06-28-2012 |
20120226179 | IMPLANTED MULTICHAMBER CARDIAC DEVICE WITH SELECTIVE USE OF RELIABLE ATRIAL INFORMATION - An implantable medical device acquires a first cardiac signal in a first heart chamber and a second cardiac signal in a second heart chamber. The device determines if the first signal is unreliable. In response to determining the first signal to be unreliable, the device switches from a first cardiac arrhythmia detection mode of operation to a second cardiac arrhythmia detection mode of operation, the first detection mode requiring the use of both the first cardiac signal and the second cardiac signal and the second detection mode requiring the use of the second cardiac signal and not requiring the use of the first cardiac signal. | 09-06-2012 |
20130060117 | Method and Apparatus for Identifying Oversensing Using Far-Field Intracardiac Electrograms and Marker Channels - A method for identifying oversensing in implantable medical devices (IMDs), such as implantable cardioverter defibrillators (ICDs), is described. A near-field electrogram signal and a far-field electrogram signal are obtained via a near-field electrode pair and a far-field electrode pair. The near-field electrogram signal is compared to the far-field electrogram signal and a determination of whether oversensing exists is made based on the comparison. In some instances, a scheduled therapy is withheld in response to determining that oversensing exists. | 03-07-2013 |
20130079651 | EPISODE CLASSIFIER ALGORITHM - The present disclosure is directed to the classification of cardiac episodes using an algorithm. In various examples, an episode classification algorithm evaluates electrogram signal data collected by an implantable medical device. The episode classification algorithm may classify may include a sinus template and a comparison of the electrogram signal to the sinus template. Possible classifications of the cardiac episode may include, for example, unknown, inappropriate, appropriate, supraventricular tachycardia, ventricular tachycardia, ventricular fibrillation or ventricular over-sensing. | 03-28-2013 |
20130079654 | EPISODE CLASSIFIER ALGORITHM - The present disclosure is directed to the classification of cardiac episodes using an algorithm. In various examples, an episode classification algorithm evaluates electrogram signal data from a near-field channel and a far-field channel. The episode classification algorithm classifies the cardiac episode based on the evaluation of the electrogram signal data for at least one of the near-field and far-field channels. In some examples, a cardiac episode being classified may be an episode that resulted in treatment being provided by an implantable medical device. Possible classifications of the cardiac episode may include, for example, unknown, inappropriate, appropriate, supraventricular tachycardia, ventricular tachycardia, ventricular fibrillation or ventricular over-sensing. | 03-28-2013 |
20130237872 | HEART SOUND SENSING TO REDUCE INAPPROPRIATE TACHYARRHYTHMIA THERAPY - Techniques for reducing inappropriate tachyarrhythmia therapy and associated medical device systems are described. In some examples a processor is enabled to receive a cardiac electrical signal representative of electrical activity of a heart of a patient and provide an indication of cardiac electrical signal reliability. A heart sound analyzing module is enabled to receive the indication of cardiac electrical signal reliability and a heart sound signal representing sounds generated by the heart of the patient and generated by a heart sound sensor. The heart sound analyzing module selectively determines an ensemble averaged heart sound signal or detects a plurality of heart sounds from the heart sound signal in response to the indication of cardiac electrical signal reliability. | 09-12-2013 |
20130237873 | HEART SOUND SENSING TO REDUCE INAPPROPRIATE TACHYARRHYTHMIA THERAPY - A method and device for detecting a cardiac event that includes sensing cardiac electrical signals representative of electrical activity of a heart of a patient, detecting the cardiac event in response to the sensed cardiac signals, determining an indication of signal reliability corresponding to the sensed cardiac signals as being one of a reliable signal and a not reliable signal, and switching operation of the device between a first mode of determining whether the sensed signal is one of treatable and not treatable and a second mode of determining whether the sensed signal is one of treatable and not treatable in response to the determined indication of signal reliability. | 09-12-2013 |
20130289428 | METHOD AND APPARATUS FOR DISPLAY OF CARDIAC SIGNAL EPISODES WITH OVER- OR UNDER-SENSING - A medical device system senses cardiac signals and generates and stores sensing data including sensed cardiac events. A processor receiving the sensing data is configured to detect undersensed and oversensed events. The processor generates an episode display comprising event identifying codes in response to the received sensing data and produces an adjusted episode display in response to an event being identified as an undersensed event or an oversensed event. | 10-31-2013 |
20140276160 | SYSTEM AND METHOD FOR AVOIDING UNDERSENSING OF VENTRICULAR FIBRILLATION - A medical device and associated method for detecting and treating tachyarrhythmias acquires a cardiac signal using electrodes coupled to a sensing module. Cardiac events are sensed from the cardiac signal and a processing module computes a first morphology metric for each sensed cardiac event occurring during a time segment of the cardiac signal. The first morphology metrics corresponding to an event originating in a ventricular chamber are counted. The first processing module computes a second morphology metric for the time segment of the cardiac signal in response to the count of the first morphology metrics meeting a threshold number of events. The time segment is classified as a shockable segment in response to the second morphology metric meeting a detection criterion. | 09-18-2014 |
20140323894 | STAGED RHYTHM DETECTION SYSTEM AND METHOD - A medical device and associated method for detecting and treating tachyarrhythmias acquires a cardiac signal using electrodes coupled to a sensing module. During an initial detection process, a shockable cardiac rhythm is detected by a processing module configured to compare the cardiac signal to a first set of detection criteria. By analyzing the cardiac signal, the processing module establishes at least one patient-specific detection threshold during the initial detection process. Upon establishing the at least one patient-specific detection threshold, the initial detection process is stopped, and a next detection process is started which includes comparing the cardiac signal to a second set of detection criteria including the at least one patient-specific detection threshold. In some embodiments, user programming of tachyarrhythmia detection parameters is not required. | 10-30-2014 |